# A hemorheological perspective on coronary microvascular dysfunction: Association of erythrocyte parameters with angiography-derived coronary microcirculatory resistance

**Authors:** Abdulrahman AlQazzaz, Yanfeng Lu, Jasmine Yimeng Bao, Gary S. Mintz, Jiahao Feng, Yong Zhang, Shanshan Gao, Qiang Song, Feifei Ning, Hytham H. Al-Samawi, Mohsen Al-Manj, Mohammed Al-Asadi, Xin Huang, Ning Guo

PMC · DOI: 10.1371/journal.pone.0345562 · PLOS One · 2026-03-25

## TL;DR

This study finds that higher red blood cell levels are linked to increased resistance in coronary microvessels, especially in non-LAD arteries.

## Contribution

The study identifies a novel association between erythrocyte parameters and coronary microcirculatory resistance using angiography-derived metrics.

## Key findings

- Higher RBC, hematocrit, and hemoglobin levels are independently linked to increased angio-IMR.
- The association is stronger in non-left anterior descending (non-LAD) coronary vessels.
- Findings remain consistent across diabetic and non-diabetic subgroups.

## Abstract

Coronary microvascular dysfunction (CMD) contributes to myocardial ischemia in patients both without obstructive coronary artery disease (e.g., MINOCA/INOCA) and in those with co-existing epicardial stenosis. While its etiology includes structural and functional causes. hematologic parameters have been linked to cardiovascular outcomes. However, the relationship between red blood cell (RBC) markers and microvascular resistance remains poorly characterized. We aim to evaluate whether RBC parameters are correlated with the angiography-derived index of microcirculatory resistance (angio-IMR).

This retrospective study evaluated the association between red blood cell (RBC) parameters and angio-IMR in patients with intermediate coronary artery disease (30%−70% stenosis). Data were analyzed from 604 patients, comprising 733 lesions; red blood cell parameters were obtained during hospitalization prior to angiography. Coronary microcirculatory resistance was derived using the AngioPlus mQFR system. Multivariable linear regression models adjusted for confounders. Subgroup analyses assessed effect modification by diabetes status, and sensitivity analyses excluded hematocrit outliers, and analyses stratified by vessel (left anterior descending (LAD), left circumflex (LCx), right coronary artery (RCA)).

Higher RBC, Hct and Hgb were independently associated with elevated angio-IMR after full adjustment (RBC: β = 0.182, P < 0.001; Hct: β = 0.019, P < 0.001; Hgb: β = 0.006, P < 0.001). Results remained robust after excluding Hct outliers (β = 0.020, P < 0.001) and consistent across diabetic (P = 0.007) and non-diabetic subgroups (P = 0.012). The association was significant in non-LAD vessels (Hct: β = 0.022, P < 0.001) but not in LAD lesions (Hct: β = 0.008, P = 0.357).

Elevated RBC parameters are independently associated with increased microcirculatory resistance, particularly in non-LAD vessels. These findings suggest that RBC parameters may serve as clinically relevant markers of microvascular dysfunction, warranting further investigation into their prognostic and therapeutic implications.

## Linked entities

- **Diseases:** myocardial ischemia (MONDO:0024644), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** PMCH (pro-melanin concentrating hormone) [NCBI Gene 5367] {aka MCH, ppMCH}, CYGB (cytoglobin) [NCBI Gene 114757] {aka HGB, NOD, STAP}
- **Diseases:** Diabetes (MESH:D003920), microvascular (MESH:D017566), cardiomyopathy (MESH:D009202), ischemia (MESH:D007511), CBC (MESH:D006402), ST-elevation myocardial infarction (MESH:D000072657), rheumatoid arthritis (MESH:D001172), CAD (MESH:D003324), cardiovascular disease (MESH:D002318), diameter stenosis (MESH:D003251), hypercholesterolemia (MESH:D006937), microvascular spasm (MESH:D013035), impaired myocardial blood flow reserve (MESH:D054318), polycythemia (MESH:D011086), dyslipidemia (MESH:D050171), stroke (MESH:D020521), polycythemia vera (MESH:D011087), myocardial ischemia (MESH:D017202), hyperemia (MESH:D006940), thrombotic (MESH:D013927), inflammatory (MESH:D007249), INOCA (MESH:D000088442), LAD (MESH:D000094629), CHF (MESH:D006333), hypertension (MESH:D006973), MR (MESH:D008944), chronic (MESH:D002908), fibrosis (MESH:D005355), CHD (MESH:D003327), ischemic (MESH:D002545), CKD (MESH:D012080), CTO (MESH:D001157), AMI (MESH:D009203), coronary stenosis (MESH:D023921), left ventricular hypertrophy (MESH:D017379), SLE (MESH:D008180)
- **Chemicals:** adenosine (MESH:D000241), oxygen (MESH:D010100), Ado (MESH:C110027)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13016340/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13016340/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC13016340/full.md

---
Source: https://tomesphere.com/paper/PMC13016340